| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 05, 2026 |
Pyxis Oncology Inc
PYXS
|
BUY |
$6.00
Est. +241%
|
$1.76 | $2.92 |
Pending
|
$1.74
-1.1%
|
| Feb 13, 2026 |
Tyra Biosciences Inc
TYRA
|
BUY |
$53.00
Est. +76%
|
$30.10 | $40.65 |
Pending
|
$28.55
-5.1%
|
| Dec 16, 2025 |
Tyra Biosciences Inc
TYRA
|
BUY |
$37.00
Est. +67%
|
$22.11 | $40.65 |
Target Met
|
$28.55
+29.1%
|
| Dec 09, 2025 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$34.00
Est. +179%
|
$12.18 | $16.74 |
Pending
|
$13.61
+11.7%
|
| Aug 15, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$25.00
Est. +187%
|
$8.72 | $22.50 |
Miss
|
$1.27
-85.4%
|
| Aug 08, 2024 |
Tango Therapeutics Inc
TNGX
|
BUY |
$13.00
Est. +49%
|
$8.72 | $12.02 |
Miss
|
$32.90
+277.3%
|
| Jul 15, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$59.00
Est. +26%
|
$47.01 | $62.40 |
Target Met
|
$160.06
+240.5%
|
| Jun 18, 2024 |
Zentalis Pharmaceuticals Inc
ZNTL
|
SELL |
$4.00
Est. +30%
|
$5.70 | $1.01 (Low) |
Target Met
|
$3.75
+34.2%
|
| May 09, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$8.00
Est. +233%
|
$2.40 | $1.52 |
Miss
|
$3.04
+26.7%
|
| Apr 11, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$65.00
Est. +38%
|
$47.04 | $65.00 |
Bullseye Hit (±1%)
|
$64.97
+38.1%
|
| Apr 08, 2024 |
Black Diamond Therapeutics Inc
BDTX
|
BUY |
$16.00
Est. +216%
|
$5.06 | $6.75 |
Miss
|
$1.72
-66.0%
|
| Oct 23, 2023 |
Arvinas Inc
ARVN
|
BUY |
$24.00
Est. +62%
|
$14.83 | $34.09 |
Target Met
|
$7.49
-49.5%
|
| May 16, 2022 |
Harpoon Therapeutics Inc
HARP
|
SELL |
$7.00
Est. +97%
|
$231.57 | - | - |
$23.01
+90.1%
|
| May 11, 2022 |
Arcus Biosciences Inc
RCUS
|
BUY |
$42.00
Est. +75%
|
$24.01 | - | - |
$24.18
+0.7%
|
| Feb 18, 2022 |
Arvinas Inc
ARVN
|
BUY |
$98.00
Est. +42%
|
$69.02 | - | - |
$7.49
-89.1%
|
| Nov 19, 2021 |
Gilead Sciences, Inc.
GILD
|
SELL |
$67.00
Est. +0%
|
$67.14 | - | - |
$124.30
-85.1%
|